Down syndrome is a chromosomal disorder caused by a third copy of chromosome 21, occurring in 1 in 800 births. It is the most common genetic cause of mild to moderate intellectual disability. Treatment focuses on controlling symptoms and early intervention can help people with Down syndrome live productive lives. Current research shows boosting norepinephrine in mice with Down syndrome improves cognition.